ATYR

aTyr Pharma
ATYR

Overview Fund Activity

50 hedge funds and large institutions have $55.8M invested in aTyr Pharma in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 8 closing their positions.

Holders
50
Holders Change
–
Holders Change %
0%
% of All Funds
1.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
17
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GCM
1
Gruss Capital Management
New York
$2.36M
2
RIM
2
RS Investment Management
California
$6.23M
3
TCM
3
Tang Capital Management
California
$749K
4
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$1.93M
5
GPP
5
Great Point Partners
Connecticut
$197K

Top Sellers

1
EC
1
EcoR1 Capital
California
$295K
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$2.05M
3
Lord, Abbett & Co
3
Lord, Abbett & Co
New Jersey
$0
4
BBA
4
Baker Bros. Advisors
New York
$8.42M
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$106K
Name Holding Trade Value Shares
Change 		Shares
Change %
SFM
51
Sphera Funds Management
Israel
– -$358K -2,604 Closed
Citadel Advisors
52
Citadel Advisors
Florida
– -$195K -1,421 Closed
Millennium Management
53
Millennium Management
New York
– -$164K -1,192 Closed
D.E. Shaw & Co
54
D.E. Shaw & Co
New York
– -$145K -1,055 Closed
NI
55
Numeric Investors
Massachusetts
– -$122K -890 Closed
PCM
56
Prelude Capital Management
New York
– -$46K -331 Closed
Bank of America
57
Bank of America
North Carolina
– -$39K -282 Closed
1 2
3